China (Mainland)
- Product Details
Keywords
- Intermediates of Febuxostat
- High purity 4-HYDROXYTHIOBENZAMIDE
- 4-hydroxybenzothioamide
Quick Details
- ProName: Low price 4-HYDROXYTHIOBENZAMIDE
- CasNo: 25984-63-8
- Molecular Formula: C7H7NOS
- Appearance: White powder
- Application: Intermediates of Febuxostat
- DeliveryTime: Intermediates of Febuxostat
- PackAge: Special aluminum foil bag or Cardboard...
- Port: Qingdao ;Hangzhou
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.2%
- Storage: Stored in shady and cool place, placed...
- Transportation: land carriage
- LimitNum: 1 Kilogram
Superiority
Xinnuo Pharmaceutical Chemical Co., Ltd. Was established in October 2013, the regional office is mainly high and new tech Development Zone, Jinan Jinan trough. Mainly engaged in research, development and production of pharmaceutical and chemical industry of fine chemicals, the company set up under the Weifang Binhai Development Zone test base and Shijiazhuang Economic and Technological Development Zone, Jinzhou production base, is mainly responsible for research and commercial production of products. CIGNA medicine as a pharmaceutical companies in technological innovation, the introduction of the concept of innovative drug research and development, combined with the development situation both at home and abroad, established a set of innovative drug research and development system, for independent intellectual property rights of innovative drugs. At the same time, carbone also focused on the related intermediates research and development and technical services. Company management research and development team by virtue of the depth of understanding and grasp of the drug market, the use of independent new drugs and new technology research and development technology, is about to develop a good market prospects for profitable products.
Details
Xinnuo Pharmaceutical Chemical Co., Ltd. Was established in October 2013, the regional office is mainly high and new tech Development Zone, Jinan Jinan trough. Mainly engaged in research, development and production of pharmaceutical and chemical industry of fine chemicals, the company set up under the Weifang Binhai Development Zone test base and Shijiazhuang Economic and Technological Development Zone, Jinzhou production base, is mainly responsible for research and commercial production of products. CIGNA medicine as a pharmaceutical companies in technological innovation, the introduction of the concept of innovative drug research and development, combined with the development situation both at home and abroad, established a set of innovative drug research and development system, for independent intellectual property rights of innovative drugs. At the same time, carbone also focused on the related intermediates research and development and technical services. Company management research and development team by virtue of the depth of understanding and grasp of the drug market, the use of independent new drugs and new technology research and development technology, is about to develop a good market prospects for profitable products.
![(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester manufacture](http://file1.lookchem.com/300w/synthetic/2022-01-23-07/9ebf08d3-90cf-4359-bd56-1c507e7ba063.png)
![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one manufacture](http://file1.lookchem.com/cas/reactions/2021/05/27/13687201.png)